Increasing evidence indicates that the ovary contains an insulin-like
growth factor (IGF) system complete with ligands, binding proteins, an
d receptors. Through their interaction with IGF receptors on theca-int
erstitial cell surface membranes, the ligands, IGF-I and IGF-II, syner
gize with luteinizing hormone (LH) to increase ovarian androgen produc
tion. The actions of these growth factors are modulated by intraovaria
n binding proteins, especially IGFBP-1, IGFBP-2, and IGFBP-3, that enh
ance or inhibit the biological actions of the IGFs. These observations
suggest that the IGF system plays a role in normal ovarian function a
nd in the pathophysiology of ovarian hyperandrogenism and polycystic o
vary syndrome.